EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review

W Chen, J Chen, M Peng, J Luo, Y Chen, H Qiu, J Li iD

BJOG: An International Journal of Obstetrics & Gynaecology · 2023

DOI: 10.1111/1471-0528.17427 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2023. Verfasst von W Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China. Hauptthemen laut MEDLINE: Eisenmenger Complex, Premature Birth. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To clarify the real‐world outcomes in pregnant women with Eisenmenger syndrome (ES) in the new therapeutic era and provide a literature review.

Design

Retrospective case and literature review.

Setting

Tertiary referral hospital (The Second Xiangya Hospital of Central South University). Sample Thirteen women with ES delivered between 2011 and 2021.

Methods

Respective study and literature reviews. Main outcomes measures Maternal and neonatal mortality and morbidity.

Results

12/13 (92%) pregnant women were treated with targeted drugs. 9/13 (69%) of patients had heart failure, but no maternal deaths occurred. 12/13 (92%) of women chose caesarean delivery. One pregnant woman gave birth at 37 +1 weeks, and the remaining 12 (92%) patients had preterm birth. 10/13 (77%) women gave birth to live infants, of which 9/10 (90%) were low birthweight infants with a mean birthweight of 1575 g. The infant mortality rate was 1/10 (10%). Cardiac functional class improved during pregnancy, probably due to therapy; 11/13 (85%) of the pregnant women were in cardiac functional level III/IV at admission and 12 (92%) were in cardiac functional class II/III at discharge. Our literature review identified 72 cases of pregnancy with ES from 11 studies, which were characterised by a low rate of targeted drug use (28%) and a high maternal mortality rate of 24% in the perinatal period.

Conclusion

Our case series and literature review suggest that targeted drugs may be key to improving maternal mortality in ES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eisenmenger ComplexPremature BirthFemaleHumansInfant, NewbornPregnancyBirth WeightParturitionPharmaceutical PreparationsPregnancy OutcomePregnant PeopleRetrospective Studies

Stichwörter der Autor:innen

Eisenmenger syndromecongenital heart diseasepregnancypulmonary arterial hypertensiontargeted drug therapy

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China.
  • Department of Paediatrics, Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: J Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, W., Chen, J., Peng, M., Luo, J., Chen, Y., Qiu, H., & Li, J. (2023). Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17427

Vancouver

Chen W, Chen J, Peng M, Luo J, Chen Y, Qiu H, et al. Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review. BJOG: An International Journal of Obstetrics & Gynaecology. 2023. doi:10.1111/1471-0528.17427

BibTeX
@article{Chen2023,
  author = {Chen, W and Chen, J and Peng, M and Luo, J and Chen, Y and Qiu, H and Li, J},
  title = {Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2023},
  doi = {10.1111/1471-0528.17427}
}
Kostenlos starten →